P&G beauty CEO granted 9,271 stock options
P&G’s Beauty CEO received a grant of 9,271 stock options at a $146.67 exercise price, adding to his mix of direct and indirect shareholdings.
Rhea-AI Filing Summary
PROCTER & GAMBLE Co (PG) reports that Freddy P. Bharucha, CEO – Beauty, received a grant of 9,271 stock options on September 15, 2026. The options allow him to buy an equal number of common shares at an exercise price of $146.67, exercisable from September 14, 2029 and expiring September 15, 2036. Following this grant, he holds these options directly and also has direct and indirect common stock holdings, including 1,965.4595 shares held directly and additional shares held through retirement and spousal accounts. No Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 9,271 shares
Grant/Award
6 txns
Insider
Bharucha Freddy P.
Role
CEO - Beauty
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 9,271 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 9,271 contracts (Direct);
Common Stock — 1,965.4595 shares (Direct);
Common Stock — 5,623.1557 shares (Indirect, By Retirement Plan Trustee);
Common Stock — 398.45 shares (Indirect, By Spouse);
Common Stock — 3,962.9959 shares (Indirect, By Spouse, By Retirement Plan Trustee);
Common Stock — 895.98 shares (Indirect, By Spouse, International Stock Ownership Plan & Pension Plan)
Key Figures
Stock options granted: 9,271 options
Exercise price: $146.67 per share
Option exercisability date: September 14, 2029
+4 more
7 metrics
Stock options granted
9,271 options
Grant to Freddy P. Bharucha on September 15, 2026
Exercise price
$146.67 per share
Exercise price of the 9,271 stock options granted
Option exercisability date
September 14, 2029
Date options become exercisable
Option expiration date
September 15, 2036
Expiration date of granted stock options
Direct common shares
1,965.4595 shares
Direct PG common stock holdings after transactions
Indirect retirement plan shares
5,623.1557 shares
Indirect holdings by Retirement Plan Trustee
Indirect spouse shares
398.4500 shares
Indirect holdings by spouse
Key Terms
Stock Option (Right to Buy), exercise price, expiration date, indirect ownership
4 terms
Stock Option (Right to Buy) financial
"The security title reported is Stock Option (Right to Buy)"
exercise price financial
"The options carry an exercise price of 146.6700"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"The options have an expiration date of 2036-09-15"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
indirect ownership financial
"Common Stock is also reported as indirect ownership by spouse and plans"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did PG insider Freddy P. Bharucha receive in this Form 4 filing?
He received a grant of 9,271 stock options on September 15, 2026, each representing the right to buy one share of Procter & Gamble common stock at an exercise price of $146.67 per share, exercisable starting September 14, 2029.
What is the exercise price and term of the new PG stock options?
The options have an exercise price of $146.67 per share, become exercisable on September 14, 2029, and have an expiration date of September 15, 2036, after which any unexercised options would lapse.
Was the PG insider option grant made under a Rule 10b5-1 trading plan?
No. The filing’s Rule 10b5-1 checkbox is marked in a way that indicates no Rule 10b5-1 trading plan is reported for these transactions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
